Singular Research Starts XORTX Therapeutics (XRTX) at Buy-Venture, 'Bringing a DeRisked Asset to its Kidney Diseases Finish Line'

February 22, 2023 4:26 PM EST Send to a Friend
(Updated - February 22, 2023 4:32 PM EST)

Singular Research analyst Chris Sakai initiates coverage on XORTX Therapeutics ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to Premium below (Free Trial) LEARN MORE

Member Login